Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Saladax and Bristol-Myers Squibb expand collaboration

Aug. 7, 2012

PharmaEngine and Nanobiotix enter license and collaboration agreement for radioenhancer

Aug. 7, 2012

Capstone Therapeutics and LipimetiX enter joint venture

Aug. 7, 2012

Marina Biotech grants Novartis license for CRN technology

Aug. 6, 2012

U.S. university and Novartis form global alliance for anticancer T-cell immunotherapies

Aug. 6, 2012

Stiefel acquires anti-inflammatory agent from Welichem Biotech

Aug. 2, 2012

Prosetta Antiviral and Bristol-Myers Squibb form strategic alliance

Aug. 2, 2012

Idenix Pharmaceuticals restructures collaboration with Novartis Pharma

Aug. 2, 2012

Alseres Pharmaceuticals issues worldwide Altropane sublicense

Aug. 2, 2012

Second phase of malaria grant awarded to PolyMedix

Aug. 1, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...